The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO

Neurology

Volumn 74, Issue 20, 2010, Pages 1619-1626

  Fratter, C ^a   Gorman, G S ^b   Stewart, J D ^b   Buddles, M ^b   Smith, C ^a   Evans, J ^a   Seller, A ^a   Poulton, J ^c   Roberts, M ^d   Hanna, M G ^e   Rahman, S ^f   Omer, S E ^g   Klopstock, T ^h   Schoser, B ^h   Kornblum, C ⁱ   Czermin, B ^j   Lecky, B ^k   Blakely, E L ^b   Craig, K ^b   Chinnery, P F ^b   Turnbull, D M ^b   Horvath, R ^b   Taylor, R W ^b   more..

^a CHURCHILL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d HOPE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g ST GEORGE S HOSPITAL   (United Kingdom)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ UNIVERSITY HOSPITAL BONN   (Germany)

^j Medical Genetic Centre   (Germany)

^k WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL HETEROGENEITY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL GENETICS; CONTROLLED STUDY; FAMILY; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HEART DISEASE; HISTOCHEMISTRY; HUMAN; MALE; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MOLECULAR GENETICS; OPHTHALMOPLEGIA; PEO1 GENE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PTOSIS; SCHOOL CHILD; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; DNA HELICASES; DNA, MITOCHONDRIAL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUTATION; OCULOMOTOR MUSCLES; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; PHENOTYPE;

EID: 77952518584     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181df099f     Document Type: Article

References (40)

1. Horvath R, Hudson G, Ferrari G, et al. Phenotypic spectrum associated with mutations of the mitochondrial poly-merase gamma gene. Brain 2006;129:1674-1684.
2. Nishino I, Spinazzola A, Hirano M. Thymidine phosphor-ylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-692.
3. Longley MJ, Clark S, Yu Wai Man C, et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006;78:1026-1034.
4. Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000;289:782-785.
5. Hudson G, Amati-Bonneau P, Blakely EL, et al. Mutation of OPA1 causes dominant optic atrophy with external oph-thalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008;131:329-337.
6. Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008;131:338-351.
7. Tyynismaa H, Ylikallio E, Patel M, Molnar MJ, Haller RG, Suomalainen A. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. Am J Hum Genet 2009;85:290-295.
8. Spelbrink JN, Li FY, Tiranti V, et al. Human mitochon-drial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001;28:223-231.
9. Liu Z, Ding Y, Du A, Zhang B, Zhao G, Ding M. A novel Twinkle (PEO1) gene mutation in a Chinese family with adPEO. Mol Vis 2008;14:1995-2001.
10. Jeppesen TD, Schwartz M, Colding-Jørgensen E, Krag T, Hauerslev S, Vissing J. Phenotype and clinical course in a family with a new de novo Twinkle gene mutation. Neuro-muscul Disord 2008;18:306-309.
11. Virgilio R, Ronchi D, Hadjigeorgiou GM, et al. Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia. J Neurol 2008;255: 1384-1391.
12. Van Hove JL, Cunningham V, Rice C, et al. Finding twinkle in the eyes of a 71-year-old lady: a case report and review of the genotypic and phenotypic spectrum of Twinkle-related dominant disease. Am J Med Genet A 2009;149:861-867.
13. Echaniz-Laguna A, Chanson JB, Wilhelm JM, et al. A novel variation in the Twinkle linker region causing late-onset dementia. Neurogenetics 2010;11:21-25.
14. Nikali K, Suomalainen A, Saharinen J, et al. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 2005;14:2981-2990.
15. Sarzi E, Goffart S, Serre V, et al. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 2007;62:579-587.
16. Hakonen AH, Isohanni P, Paetau A, Herva R, Suoma-lainen A, Lönnqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007;130:3032-3040.
17. Lönnqvist T, Paetau A, Valanne L, Pihko H. Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 2009;132:1553-1562.
18. Hudson G, Deschauer M, Busse K, Zierz S, Chinnery PF. Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism. Neurology 2005; 64:371-373.
19. Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 2004;14:237-245.
20. Murphy JL, Blakely EL, Schaefer AM, et al. Resistance training in patients with single, large-scale deletions of mi-tochondrial DNA. Brain 2009;131:2832-2840.
21. Hudson G, Deschauer M, Taylor RW, et al. POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions Neurology 2006;66:1439-1441.
22. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Oxford: Blackwell; 2002.
23. Deschauer M, Kiefer R, Blakely EL, et al. A novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia. Neuromuscul Disord 2003; 13:568-572.
24. Van Goethem G, Martin JJ, Van Broeckhoven C. Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the patho-genesis of human mitochondrial DNA instability and the initiation of a genetic classification. Neuromolecular Med 2003;3:129-146.
25. Winterthun S, Ferrari G, He L, et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial poly-merase gamma mutations. Neurology 2005;64:1204-1208.
26. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989;339:309-311.
27. Van Goethem G, Dermaut B, Löfgren A, Martin JJ, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001;28:211-212.
28. Taanman JW, Rahman S, Pagnamenta AT, et al. Analysis of mutant DNA polymerase gamma in patients with mito-chondrial DNA depletion. Hum Mutat 2009;30:248-254.
29. Luoma P, Melberg A, Rinne JO, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004;364:875-882.
30. Lewis S, Hutchison W, Thyagarajan D, Dahl HH. Clinical and molecular features of adPEO due to mutations in the Twinkle gene. J Neurol Sci 2002;201:39-44.
31. Agostino A, Valletta L, Chinnery PF, et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003;60: 1354-1356.
32. Kiechl S, Horváth R, Luoma P, et al. Two families with autosomal dominant progressive external ophthalmople-gia. J Neurol Neurosurg Psychiatry 2004;75:1125-1128.
33. Houshmand M, Panahi MS, Hosseini BN, Dorraj GH, Tabassi AR. Investigation on mtDNA deletions and twinkle gene mutation (G1423C) in Iranian patients with chronic progressive external ophthalmoplegia. Neurol India 2006;54:182-185.
34. Naïmi M, Bannwarth S, Procaccio V, et al. Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple deletions or depletion of mitochondrial DNA by a dHPLC-based assay. Eur J Hum Genet 2006;14:917-922.
35. Baloh RH, Salavaggione E, Milbrandt J, Pestronk A. Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle. Arch Neurol 2007;64:998-1000.
36. Rivera H, Blázquez A, Carretero J, et al. Mild ocular my-opathy associated with a novel mutation in mitochondrial twinkle helicase. Neuromuscul Disord 2007;17:677-680.
37. Negro R, Zoccolella S, Dell'aglio R, et al. Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthal-moplegia. Neuromuscul Disord 2009;19:423-426.
38. Vandenberghe W, Van Laere K, Debruvne F, Van Broeck-hoven C, Van Goethem G. Neurodegenerative parkinson-ism and progressive external ophthalmoplegia with a Twinkle mutation. Mov Disord 2009;24:308-309.
39. Suomalainen A, Majander A, Wallin M, et al. Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical and molecular genetic features of the 10q-linked disease. Neurology 1997;48:1244-1253.
40. Li FY, Tariq M, Croxen R, et al. Mapping of autosomal dominant progressive external ophthalmoplegia to a 7-cM critical region on 10q24. Neurology 1999;53: 1265-1271.